Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Procos S P A has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. The current prosecution involves 1 distinct examiner and 1 distinct art unit, concentrating the company's active matters into a single point of review. This concentration within 1 distinct art unit means that the company's current patenting efforts are focused on a specific technical area within the broader pharmaceutical field. For the practitioner, this simplifies the management of the portfolio, as there is only 1 pending office action to monitor and address. This focused approach allows for a more consistent legal strategy across the company's current Biotechnology & Pharmaceuticals filings.
ADLAM, CHANTAL PETA-GAYE is identified as the busiest examiner, with 1 pending office action. This single action represents the total pending workload for the portfolio, as the busiest examiner pending count is 1. Success in this matter depends on addressing the specific concerns raised by this examiner in the Biotechnology & Pharmaceuticals sector. Since there is only 1 distinct examiner involved, the legal strategy can be tailored specifically to this individual's examination style. Understanding the examiner's preferences and historical patterns will be key to moving this single pending case toward a successful conclusion.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ADLAM, CHANTAL PETA-GAYE | 1 | 53.5% | +27.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17628578 | PROCESS FOR THE PREPARATION OF AMORPHOUS MIDOSTAURIN WITH A LOW CONTENT OF RESIDUAL ORGANIC SOLVENT | ADLAM, CHANTAL PETA-GAYE | 30d |
| Art Unit | Apps |
|---|---|
| 1622 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17628578 | PROCESS FOR THE PREPARATION OF AMORPHOUS MIDOSTAURIN WITH A LOW CONTENT OF RESIDUAL ORGANIC SOLVENT | ADLAM, CHANTAL PETA-GAYE | 1622 | §103 | Non-Final OA | 30d | Pending | Jan 20, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial